Inhaled antimuscarinic agents and COPD

Monaldi Archives for Chest Disease

Volumn 51, Issue 1, 1996, Pages 52-53

  Nardini, S ^a  

^a Ospcdale E Morelli   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FENOTEROL; FLUORTROPIUM; IPRATROPIUM BROMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXITROPIUM BROMIDE; SALBUTAMOL; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG;

BRONCHODILATING ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; SIDE EFFECT; SPIROMETRY; VITAL CAPACITY;

EID: 0029923264     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (2)

1. Maesen FPV, Smeets JJ, Sledsens TJH, Wald FDM, Cornelissen PJG, on behalf of a Dutch Study group. - Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1506-1513.
2. Ikeda A, Nishimura K, Koyama H, Izumi T. - Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease. Thorax 1995; 50: 62-66.